{"entity":{"id":"nct05620017","kind":"trial","name":"Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8008 for Injection","aka":[],"tldr":"An early trial studying the safety and activity of experimental treatment. Its registry status does not establish patient benefit.","summary":"Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8008 for Injection. ClinicalTrials.gov record last updated 2026-02-09: recruiting. Enrollment is planned at 182 participants. Primary completion is estimated at 2027-05-31. No tabular results are posted on ClinicalTrials.gov; this does not exclude separate publications.","status":"recruiting","asOf":"2026-10-06","links":[{"label":"ClinicalTrials.gov NCT05620017","url":"https://clinicaltrials.gov/study/NCT05620017"}],"tags":[],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":["trop2"],"drugs":["bat8008"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":["ClinicalTrials.gov record last updated 2026-02-09: recruiting. Enrollment is planned at 182 participants. Primary completion is estimated at 2027-05-31. No tabular results are posted on ClinicalTrials.gov; this does not exclude separate publications."],"nct":"NCT05620017","phase":"1","setting":"Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8008 for Injection","sponsor":"Bio-Thera Solutions","started":"2022-11-30","startedType":"actual","enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct05620017/","neighbours":{"target":[{"id":"trop2","kind":"target","name":"TROP2","route":"/targets/trop2/"}],"drug":[{"id":"bat8008","kind":"drug","name":"BAT8008","route":"/drugs/bat8008/"}]}}